Baseline | 3 months | % Reduction from baseline | P valuea | 12 monthsb | % Reduction from baseline | P valuea | |
---|---|---|---|---|---|---|---|
No. of ablated fibroids | 89 | 89 | 43 | ||||
No. of subjects | 49 | 49 | 28 | ||||
Perfused fibroid volume (cm3) | 18.3 ± 20.6 9.5 (0.3–77.0) | 5.8 ± 9.6 1.6 (0.0–45.7) | 68.1 ± 28.6 % 76.9 % (−33.3 to 100 %) | <.001 | 6.6 ± 11.3 1.0 (0.0–56.1) | 67.4 ± 31.9 % 73.3 % (−32.7 to 100 %) | <.001 |
Total fibroid volume (cm3) | 18.8 ± 21.4 9.5 (0.3–77.0) | 8.0 ± 12.0 1.9 (0.0–56.3) | 54.7 ± 37.4 % 62.5 % (−85.7 to 100 %) | <.001 | 6.8 ± 11.4 1.2 (0.0–56.1) | 66.6 ± 32.1 % 73.3 % (-32.7–100 %) | <.001 |